BACKGROUND To estimate the level of procalcitonin in neonatal sepsis and to compare the sensitivity and specificity of procalcitonin with that of WBC count, immature to total neutrophil ratio, CRP level and blood cultures. MATERIALS AND METHODS This study was conducted on neonates admitted to the Neonatal Intensive Care Unit, GVMCH, Vellore, Tamilnadu with a clinical diagnosis of neonatal sepsis over a period of 8 months, July 2015 to February 2016. Before commencing anti-microbial therapy, blood samples were collected from 50 neonates who were clinically diagnosed as sepsis and subjected to sepsis workup, which includes complete blood count, immature to total neutrophil ratio (I/T ratio), CRP, blood culture and procalcitonin levels. CRP levels were semi-quantitatively assessed by Rapid Latex agglutination slide method (Mediclone Biotech) and the cutoff value was 6 mg/dL. Procalcitonin was assessed by the Human Procalcitonin ELISA kit. (Sincere Biotech) and the readings were read in Biorad microplate reader. Data were expressed as sensitivity, specificity and statistical significance was assessed by Chi-Square test. RESULTS Out of 50 neonates CRP level was increased in 26 neonates, 14 in proven sepsis group, 8 in suspected sepsis group and 4 in clinical sepsis group. Procalcitonin level was increased in 12 neonates out of 50, 8 in proven sepsis and 4 in clinical sepsis. The sensitivity of procalcitonin was 36.36% and the specificity was 85.71%. CONCLUSION The low sensitivity of procalcitonin can be attributed to the small sample size and may be due to perinatal factors, so this level should be correlated with clinical findings, CRP level and blood culture.